At a glance
ClinicalIndex Comparison RecordN/ACompleted· 150 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Iron-mediated Vascular Disease in Sickle Cell Disease.
In Brief
An observational study for Sickle Cell Disease. Completed, enrolled 150 participants across 1 site.
Detailed Summary
The purpose of this research study is to determine the frequency and severity of iron overload in patients with Sickle Cell Anemia and its relationship to blood vessel function. The investigators hypothesize that intermittent transfusions that these patients receive during hospitalizations produces significant iron overload and impairs blood vessel relaxation.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsSickle Cell Disease
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartDec 2009
First PostedNov 2010
Primary CompletionOct 2018
TodayJul 2026
First PostedNov 15, 2010
Enrollment StartDec 1, 2009
Primary CompletionOct 1, 2018
TodayJul 2, 2026
Enrollment to primary: 8.8 yearsPosted 15.6 years ago